An Open Label, Dose-Proportionality, Bioavailability and Dose- Titration Investigation of the Pharmacokinetics, Metabolism, Efficacy and Safety of Two Testosterone Matrix Transdermal Systems (28 cm2 and 48 cm2) in Hypogonadal Men.
Phase of Trial: Phase II
Latest Information Update: 31 Dec 2012
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- 08 Feb 2012 Actual patient number is 40 according to ClinicalTrials.gov.
- 08 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.